Home / Products / Cancer (Tumor) Cell Lines / SKM-1
SKM-1
Datasheet Protocol

SKM-1

Cat. No. ARC0827
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Blood (peripheral blood)

Growth Properties:

Suspension

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

SKM-1 is a cancer cell line of acute myeloid leukemia (aml), isolated from in situ; peripheral blood.

Recommended Products

LCK Knockout jurkat Polyclonal Cells LCK Knockout jurkat Polyclonal Cells Cat. No. ARG12900 FLAD1 Knockout A549 Polyclonal Cells FLAD1 Knockout A549 Polyclonal Cells Cat. No. ARG10315 ABL1 Knockout Raji Polyclonal Cells ABL1 Knockout Raji Polyclonal Cells Cat. No. ARG21007 ADCY3 Knockout A549 Polyclonal Cells ADCY3 Knockout A549 Polyclonal Cells Cat. No. ARG38640 EGFR Knockout A2780 Polyclonal Cells EGFR Knockout A2780 Polyclonal Cells Cat. No. ARG40729 LPGAT1 Knockout 786-O Polyclonal Cells LPGAT1 Knockout 786-O Polyclonal Cells Cat. No. ARG5340
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Blood (peripheral blood)
Disease:
Acute myeloid leukemia (AML)
Morphology:
Lymphoblast-like
Growth Mode:
Suspension
Age:
76 years
Sex of Donor:
Male
Derived From Site:
In situ; Peripheral blood
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

NUAK1 Knockout SKOV3 Polyclonal Cells

NUAK1 Knockout SKOV3 Polyclonal Cells

Cat. No. ARG12406
 ABHD4 Knockout Raji Polyclonal Cells

ABHD4 Knockout Raji Polyclonal Cells

Cat. No. ARG21002
 ADGRB3 Knockout HAP1 Polyclonal Cells

ADGRB3 Knockout HAP1 Polyclonal Cells

Cat. No. ARG21672
 GRM7 Knockout HAP1 Polyclonal Cells

GRM7 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22409
 HS3ST1 Knockout KYSE150 Polyclonal Cells

HS3ST1 Knockout KYSE150 Polyclonal Cells

Cat. No. ARG36238
 CAB39 Knockout NCI-H1299 Polyclonal Cells

CAB39 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG41703